Lymphocyte-to-monocyte ratio is a short-term predictive marker of ulcerative colitis after induction of advanced therapy

Advanced therapies for patients with mild-to-severe ulcerative colitis (UC) may result in treatment failure. We examined whether the lymphocyte-to-monocyte ratio (L/M ratio) could predict the failure of advanced therapies. This retrospective, observational, cohort study included 73 patients who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Natsuki, Asai, Yusuke, Miyazu, Takahiro, Tamura, Satoshi, Tani, Shinya, Yamade, Mihoko, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178621/
https://www.ncbi.nlm.nih.gov/pubmed/35692303
http://dx.doi.org/10.1093/gastro/goac025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178621/
https://www.ncbi.nlm.nih.gov/pubmed/35692303
http://dx.doi.org/10.1093/gastro/goac025

Ejemplares similares